Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Bacteria
|
gptkbp:administeredBy |
oral route
|
gptkbp:approvedBy |
many countries
|
gptkbp:contraindication |
pregnancy
immunocompromised individuals |
gptkbp:discoveredBy |
Germanier and colleagues
|
gptkbp:discoveredIn |
1975
|
gptkbp:form |
enteric-coated capsule
|
gptkbp:geneticCharacteristic |
Vi antigen negative
galE mutation |
https://www.w3.org/2000/01/rdf-schema#label |
Salmonella typhi Ty21a
|
gptkbp:marketedAs |
gptkb:Vivotif
|
gptkbp:protectedBy |
typhoid fever
|
gptkbp:regulates |
FDA approved
EMA approved |
gptkbp:relatedTo |
gptkb:Salmonella_typhi_Ty2
|
gptkbp:storage |
refrigerated
|
gptkbp:subclassOf |
gptkb:Salmonella_enterica_serovar_Typhi
|
gptkbp:usedFor |
typhoid vaccine
|
gptkbp:vaccineType |
live attenuated vaccine
|
gptkbp:WHOStatus |
gptkb:World_Health_Organization_Model_List_of_Essential_Medicines
|
gptkbp:bfsParent |
gptkb:Vivotif
|
gptkbp:bfsLayer |
7
|